We have heard that there is a shortage in supply of the Requip XL which may lead to you having difficulties getting hold of this drug.
The company responsible for the manufacture of the drug, GlaxoSmithKline, expects a normal supply of the 2mg and 8mg Requip XL tablets to resume by early May. However, the 4mg tablet is not expected to be back in supply until early June.
They told us that: “There has been a delay in the availability of an active pharmaceutical ingredient used to manufacture Requip XL.We are aware and regret any impact that this interruption to supply is having on both patients and health care professionals alike. GlaxoSmithKline is working closely with the manufacturer to resolve this problem.”
No need for panic
We spoke to Dr Janine Barnes, a neurology specialist pharmacist who believes that as the shortage shouldn't be too long most larger pharmacies will have enough stock to cover the period.
If you cannot get access to Requip XL there are many direct substitutes that can be used for Requip XL which include:
• Ralnea XL
• Repinex XL
• Spiroco XL
• Ropinirole modified release
In some cases where people have been specifically prescribed Requip XL, they may need to get a new prescription for ropinirole modified release. This will allow pharmacists to give a substitute for Requip XL should it have run out (please check whether you can get access to the drug before doing this)
If you are concerned about accessing Requip XL, we recommend you speak to your healthcare professional.
If you are having difficulty accessing Requip XL please do let us know so we can keep an eye on the problem. We will let you know as soon as there are any updates